DR3:TL1A Inhibitor Screening Assay Kit

Only %1 left
Catalog #
82241
As low as $1,250 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The DR3:TL1A Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of the interaction between DR3 (Death Receptor 3) and TL1A (TNF-like ligand 1A). This kit comes in a convenient 96-well or 384-well format, with biotin-labeled TL1A, purified DR3, streptavidin-labeled HRP, and assay buffer for 100 or 400 binding reactions.

Figure 1: DR3:TL1A Inhibitor Screening Assay Kit workflow diagram.
First, DR3 is coated on a 96-well or 384-well plate. Next, biotinylated TL1A is incubated with DR3. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence. The chemiluminescence signal is proportional to the binding of DR3:TL1A

Need us to run inhibitor screens or profile your compounds against DR3:TL1A? Check out our Immunotherapy Biochemical Screening Services.

Synonyms
TNF ligand-related molecule 1, Vascular endothelial cell growth inhibitor, Tumor necrosis factor ligand superfamily member 15, TL1, VEGI, TNFSF15
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Materials Required But Not Supplied
  • 1x PBS (Phosphate Buffer Saline)
  • PBST Buffer (1x PBS containing 0.05% Tween-20)
  • Plate reader capable of reading chemiluminescence
  • Adjustable micropipettor and sterile tips
  • Orbital shaker
Format

96 Reactions

Catalog # Name Amount Storage
101882 TL1A, His-Tag, Avi-Tag, Biotin-Labeled* 5 µg -80 °C
  DR3* 25 µg -80 °C
  5x PP-02 Buffer 4 ml -20 °C
  Blocking Buffer 7 40 ml +4 °C
79742 Streptavidin-HRP 10 µl +4 °C
79670 ELISA ECL Substrate A (translucent bottle) 6 ml  Room Temp
ELISA ECL Substrate B (brown bottle) 6 ml  Room Temp
79699 96-well white microplate 1 Room Temp

* The concentration of protein is lot-specific and will be indicated on the tube containing the protein.

384 Reactions

Catalog # Name Amount Storage
101882 TL1A, His-Tag, Avi-Tag, Biotin-Labeled* 2 x 5 µg -80 °C
  DR3* 2 x 25 µg -80 °C
  5x PP-02 Buffer 4 ml -20 °C
  Blocking Buffer 7 2 x 40 ml +4 °C
79742 Streptavidin-HRP 2 x 10 µl +4 °C
79670 ELISA ECL Substrate A (translucent bottle) 2 x 6 ml  Room Temp
ELISA ECL Substrate B (brown bottle) 2 x 6 ml  Room Temp
78188 384-well white microplate 1 Room Temp

* The concentration of protein is lot-specific and will be indicated on the tube containing the protein.

UniProt #
O95150
Background

DR3 (death receptor 3), also known as tumor necrosis factor receptor superfamily member 25 or TNFRSF25, is a membrane receptor of the tumor necrosis factor receptor superfamily of proteins (TNFRSF), which associates with TL1A (TNF-like protein 1A) in T and NK cells. DR3 has been recognized as a significant anti-apoptotic and differentiation factor and it is a co-stimulatory receptor. TL1A, also called TNFSF15, is a member of the tumor necrosis factor family. It is expressed in different immune cells, such as monocyte, macrophage, dendritic cell, T cell and non-immune cells. TL1A competitively binds to DR3, having a higher affinity for DcR3 (decoy receptor 3), providing stimulatory signal for downstream signaling pathways. It then regulates proliferation, activation, apoptosis, and chemokine production in effector cells. The role of DR3 in T cell activation, and consequently in cytokine secretion and cell proliferation, makes it an attractive target in cancer therapy. Inhibition of DR3-TL1A interaction has substantial therapeutic potential in the treatment of solid tumors.

References

Xu, W. D., et al., 2022 Front. Immunol. 13: 1-10.
Zwolak, A., et al., 2022 Sci. Rep. 12(1): 20538.